Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
VHT
421
HOLDINGS
2%
ALSO IN THNR
THNR
18
HOLDINGS
50%
ALSO IN VHT
SECTOR DRIFT (VHT minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.1% | 10.6% | 10.6% |
|
ABBVIE INC | 6.8% | 5.7% | 5.7% |
|
MERCK & CO. INC. | 5.0% | 5.3% | 5.0% |
|
AMGEN INC | 3.1% | 5.9% | 3.1% |
|
GILEAD SCIENCES INC | 2.6% | 5.5% | 2.6% |
VHT Overweight Relative to THNR
|
JOHNSON & JOHNSON | 8.6% |
|
UNITEDHEALTH GROUP INC | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.4% |
|
ELI LILLY & CO | 2.4% |
|
ABBOTT LABORATORIES | 2.4% |
|
INTUITIVE SURGICAL INC | 2.1% |
|
DANAHER CORP | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
|
BRISTOL-MYERS SQUIBB CO | 1.7% |
 |
MEDTRONIC PLC | 1.6% |
VHT Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -8.9% |
 |
ASTRAZENECA PLC | -5.5% |
 |
CHINA PHARMACEUTICAL GROUP | -5.4% |
 |
INNOVENT BIOLOGICS, INC. | -5.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.7% |
|
VIKING THERAPEUTICS, INC. | -4.6% |
|
REGENERON PHARMACEUTICALS | -4.0% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.9% |
|
ZEALAND PHARMA A/S | -3.7% |
 |
HANMI PHARM CO LTD | -3.5% |